Gilead Sciences and CVS Partner for Hepatitis C Drug

January 9, 2015 12:47 PM

4 0

CVS and Gilead Sciences strike an exclusive deal for hepatitis C drugs Sovaldi and Harvoni. The total cost of treatment via Sovaldi can reach up to $84,000 for 12 weeks. (Photo : Gilead Sciences)

CVS and Gilead Sciences strike an exclusive deal for hepatitis C drugs Sovaldi and Harvoni. The total cost of treatment via Sovaldi can reach up to $84,000 for 12 weeks.

Read more

To category page

Loading...